Analyst Ratings for Kyverna Therapeutics Inc (KYTX)
KYTX Rating Summary
KYTX Price Target Summary
- Highest: $33.00 (Morgan Stanley)
- Lowest: $20.00 (H.C. Wainwright)
- Average: $28.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.67 (+253.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$28.67 (+253.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2025 | William Blair | Sami Corwin | New Coverage | Outperform (N/A) |
N/A (N/A) |
3.30 (8.10) |
145.45% | Details |
| 5/27/2025 | H.C. Wainwright » Updated 10/27/2025 |
Mitchell S. Kapoor | Upgrade | Buy (Neutral) |
20.00 (10.00) |
2.27 (8.10) |
256.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
